May 8, 2020

Webcast: Patient Assistance in the Wake of COVID-19

Join experts from Lash Group and Xcenda for a panel discussion.

As the U.S. economy continues to feel the ripple effect of the COVID-19 pandemic,will patients be able to afford their medications?

As the U.S. economy continues to feel the ripple effect of the coronavirus pandemic and more Americans lose their jobs, will patients be able to afford their medications? It’s a question that matters across therapeutic areas and one that will impact manufacturers’ commercialization strategies, especially as it relates to patient and provider support. 

Join a panel of experts from Lash Group and Xcenda on Friday, May 8th at 12:00 PM EDT as they offer insights on:

  • How the COVID-19 pandemic will impact insurance coverage
  • The resulting affordability challenges patients will face
  • How manufacturers can adapt their patient assistance programs to ensure access to important therapies

Lash Group Experts

Mark Beightol lash group
Mark Beightol
Vice President, Client Delivery
Nicole Dunn
Vice President, Client Delivery
Fort Mill, SC
rose herring lash group
Rose Herring
Senior Director, Marketing
jack mcguire lash group
Jack McGuire, Pharm.D.
Vice President, Pharmacy Services

Xcenda Experts

Corey Ford
Corey Ford, MHA
Director, Reimbursement & Policy Insights
Xcenda
Melissa Mulchahey
Vice President, Field Services Client Engagement and Business Development
Xcenda

Navigating COVID-19: Simplifying the Path to Better Patient Outcomes (Virtual Event) 

8/3/2020 12:00:00 AM

Webcast series: Leveraging AI within eBV to optimize speed to therapy

4/29/2020 12:00:00 PM - 5/18/2020 1:00:00 PM

Hub and SPP Model Optimization Conference

2/24/2020 7:30:00 AM